| NANOBIOTIX INH. EO-,03 |
| Frankreich |
| Gesundheit |
| FR0011341205 / A1J7EB |
| 5NR (Frankfurt) |
| FRA:5NR, ETR:5NR, 5NR:GR |
| - |
| https://www.nanobiotix.co.. |
|
Nanobiotix S.A. is a late-stage clinical biotechnology company specializing in physics-based nanomedicines to revolutionize cancer treatment. Headquartered in Paris, France, with offices in the United States, it pioneers nanotechnology that enhances ..
>Volltext.. |
| 1311.61 Mio. EUR |
| 1307.32 Mio. EUR |
| 8.52 Mio. EUR |
| -31.77 Mio. EUR |
| -53.9 Mio. EUR |
| -1.11 EUR |
| 108.69 Mio. EUR |
| 113.05 Mio. EUR |
| -40 Mio. EUR |
| 1.29 |
| -76.92% |
| -57.94% |
| - |
| - |
| - |
| - |
| NANOBIOTIX |
| 27.10.26 |
|
||||
|